Lefamulin for Treating Community-acquired Bacterial Pneumonia in Adult Patients Aged <65 Years
- PMID: 31822903
- DOI: 10.1093/cid/ciz1173
Lefamulin for Treating Community-acquired Bacterial Pneumonia in Adult Patients Aged <65 Years
Comment in
-
Reply to Tang and Lai.Clin Infect Dis. 2020 Sep 12;71(6):1583. doi: 10.1093/cid/ciz1174. Clin Infect Dis. 2020. PMID: 31822883 No abstract available.
Comment on
-
Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.Clin Infect Dis. 2019 Nov 13;69(11):1856-1867. doi: 10.1093/cid/ciz090. Clin Infect Dis. 2019. PMID: 30722059 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
